KLRK1 and neoplasm: In order to determine if NKG2D-Fc-IL2 can bind to NKG2D ligand-expressing tumor cells while preserving the IL-2 functionality of promoting T cell proliferation, we incubated NKG2D-Fc-IL2 with irradiated MOSEC tumor cells, alongside equivalent assays with relevant control proteins.